Apple and the FDA are looking to address the spread of a virus that has killed more than 200,000 people and caused more than 100,000 cases in the United States and the world.
As the nation’s coronavirus campaign nears its sixth week, the public health community is preparing for the next round of announcements, which could include the first ever coronaviruses vaccine.
“We expect the FDA to be announcing that next week,” said Mark Pritchard, an epidemiologist at Johns Hopkins University School of Medicine.
If confirmed, the next COVID vaccine could be as close to the public-health consensus as is possible.
That’s because the virus is spread through close contact and is highly contagious, meaning anyone who is sick could spread it.
Pritchard said a coronaviral vaccine would likely have to be given in doses of a few hundred milligrams per day, about twice the current level recommended by the FDA.
The next COIDS-19 coronavirodisease update, which was announced last week, is expected to include: – a new, single-dose vaccine to be tested for the virus in Texas and elsewhere, as well as a third-party study of its effectiveness.
– The development of a more potent virus to be used in the first dose of the vaccine in the US.
– The development and distribution of a second dose of vaccine in California, and possibly other states.
This would be the first time that a coronovirus vaccine has been approved for use in the U.S.
Pritcher said there are a lot of unanswered questions about the effectiveness of the new vaccine.
“What are the tolerability and safety issues with this vaccine?
What is the efficacy?
How long do we need to be exposed to this virus to make it effective?” he said.
We don’t have any information on that.
There is no good data on the efficacy of that vaccine yet.
In fact, the only information we have about efficacy is a paper that’s been published in the journal of the American Academy of Allergy, Asthma and Immunology.
It’s not a new vaccine and it’s not very well designed.
However, if approved, Pritchers vaccine would be one of the first to target the virus.
Because the US is so spread thin, the vaccine would probably be delivered to patients in hospitals rather than on their way to the doctor.
There are some important limitations to the coronavis vaccine, according to the CDC: – It would be given only once in a patient’s lifetime.
A second dose would have to take longer to develop than a first one, and would likely require a longer time for the patient to recover.
And it’s unclear if there would be enough vaccine to go around, or whether the doses would be distributed in sufficient numbers to avoid over-dosing.
Experts said that could leave some patients with more serious side effects than with the current vaccines.
“We think there are going to be some more serious complications than with any of the vaccines that are available today,” Pritcher noted.
For now, the most pressing issue in terms of the virus’ effectiveness has been how to stop it from spreading through the medical system, Prowler said.
“So far, we have been successful at stopping the virus from going to the medical systems, but there are still a lot more cases of it going to people who are already sick and not being detected,” he said, adding that it could take years before coronavids is more effectively treated.
So what is the best way to prevent the virus spreading through healthcare systems?
The answer is, it’s probably better not to get sick.
Instead, Preeters best approach is to prevent people from getting infected in the future, he said.
“In other words, avoid becoming infected and stay healthy, Pritzers advice to doctors and nurses.
Even then, you could be at risk of spreading the virus through other healthcare workers, he added.
As for those who might be infected in time, Proust suggests a “sensible” approach: “Keep your hands out of your pockets.
Don’t touch anyone.
“(Copyright 2017 CBS Local Media, a division of CBS Radio Inc. All Rights Reserved.
This material may not be published, broadcast, rewritten, or redistributed.)
Follow CBSMIAMI.COM on Twitter and Facebook